Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?

University of Minnesota (UMN)

Status and phase: Withdrawn; Phase 4

Conditions: Clavicle Fracture

Treatments: Drug: Liposomal Bupivacaine; Drug: Bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT03020563

1611M99381

Details and patient eligibility

About

To determine whether liposomal bupivacaine wound infiltration decreases pain scores and narcotic use when compared to bupivacaine alone after open reduction internal fixation of midshaft clavicle fractures.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Mid-shaft Clavicle Fracture treated with ORIF

Exclusion criteria

• Unable to be contacted for 72 hours post surgery
• Other concurrent surgical procedures
• Chronic narcotic user

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups, including a placebo group

Liposomal Bupivacaine

Active Comparator group

Description:

Time release Bupivacaine

Treatment:

Drug: Liposomal Bupivacaine

Bupivacaine

Placebo Comparator group

Description:

Immediate Acting Bupivacaine

Treatment:

Drug: Bupivacaine